Fibromyalgia Clinical Trial
Official title:
Efficacy of Qigong Exercise on Sleep Quality and Heart Rate Variability in Patients With Fibromyalgia
This study aims to determine any significant efficacy of qigong exercise on sleep quality and heart rate variability in patients with fibromyalgia.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | June 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 30 Years to 50 Years |
Eligibility | Inclusion Criteria: - All patients are female - Age from 30 to 50 years - Body mass index (BMI) from 18.5 to 34.9 kg/m2. - Patients will include if they have been diagnosed with FM by rheumatologists as fulfilling all the ACR criteria (1990, 2011 and 2016) - All patients are ambulant independently - Stable medication pattern for at least 2 months. Exclusion Criteria: - Presence of any immune diseases or comorbidities that could explain the main symptomatology of FM - The presence of brain damage, dementia, or neurological disease. - The presence of psychiatric disorders or current major depressive episode - Endocrine disorders - Fractures in upper limb or lower limb - Participation in regular exercise training of any type in the previous 3 months. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Physical therapy Cairo University | Cairo | Giza |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sleep quality | The Pittsburgh Sleep Quality Index (PSQI): It is used to determine self-reported sleep quality and sleep disturbances for the preceding month. It is a consistent and easy for patients and health-care providers in interpreting the indicators of sleep quality. It is a 19-item test and consists of seven components: (1) subjective sleep quality, (2) sleep latency, (3) sleep duration, (4) sleep efficiency, (5) sleep disturbance, (6) sleeping medication use and (7) daytime dysfunction. Each component is scored from 0 to 3, and , each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality. PSQI (poor sleep: global score > 5 | evaluated beginning and through study completion, an average of8 weeks | |
Primary | Heart Rate variability | Smart watch-derived HRV provides a practical alternative with excellent accuracy compared with ECG-based HRV for global markers and those characterizing lower frequency components. However, caution is warranted with HRV markers that predominantly assess short-term variability. | evaluated beginning and through study completion, an average of8 weeks short time 5minutes | |
Secondary | Quality of Life o measure the quality of life of patients with problems found fibromyalgia. | The FIQR consists of 21 individual questions across three linked domains: function, overall impact and symptoms. All questions pertain to experiences during the past 7 days and are scored using an 11-point numeric rating scale (0 to 10, with 10 denoting the worst possible condition). The function domain contains nine questions addressing activities of daily living .The overall impact domain consists of two questions relating to the overall impact of fibromyalgia on function and overall impact of symptom severity symptoms domain contains 10 questions and evaluates symptoms commonly reported by fibromyalgia. The total FIQR score (out of 100) is the sum of the three modified domain scores, that is: the summed score for the function domain (range 0 to 90, divided by 3), the score for overall impact domain (range 0 to 20) and the score for the symptoms domain (range 0 to 100, divided by 2). scores is classified as mild (=40), moderate (>40 & =63), and severe (>63) | evaluated beginning and through study completion, an average of8 weeks | |
Secondary | pain self-administered questionnaire | is a self-administered or interviewer-administered pain rating scale with four questions related to pain intensity, with responses rated on a numerical rating scale ranging from 0 to 10; "0" is "no pain" and "10" is "pain as bad (excruciating) as you can imagine". Cancer patients rate their worst, least and average pain in the last 24 h and, the pain experienced at the time they were responding to the questionnaire. Pain interference on general activity, mood, walking ability, normal work, relationships with other people, sleep and enjoyment of life were rated on a numerical scale from 0 = "Does not interfere" to 10 = "Interferes completely". The scale comprised of a diagram of a human figure for locating areas of pain and, questions about pain medications and the percentages of pain relief achieved with medications in the last 24 h. | evaluated beginning and through study completion, an average of8 weeks | |
Secondary | Fatigue :prevalence and severity of fatigue | The Fatigue Severity Scale (FSS):one of the most frequently used inventories for measuring fatigue in people with chronic illnesses. The original FSS is a nine-item questionnaire to measure fatigue severity as a unidimensional concept. Some measures are multidimensional and assess several dimensions of fatigue, such as mental and physical fatigue, but the FSS is designed to measure fatigue in a single dimension using the nine items, which represent a single scale. Each FSS item consists of statements that are scored on a seven-point type scale ranging from 1 ("strongly disagree") to 7 ("strongly agree"). The mean of the nine item scores is used as the FSS score, which ranges from 1 to 7. | evaluated beginning and through study completion, an average of8 weeks | |
Secondary | Depression and Anxiety assess Depression and Anxiety | HADS to assess the levels of anxiety and depression among patients in nonpsychiatric hospital clinics. Items describing somatic symptoms of depression were eliminated from the scale to reduce the effect of physical illness on the depression scores. 14-item self-reporting scale measuring anxiety (7-item subscale) and depression (7-item subscale). Each item is scored on a 4-level Likert type scale ranging from 0 to 3. Mean subscale scores are either normal (0-7), borderline (8-10), or positive for anxiety or depression (11-21). This translates into a maximal score of 21 on each subscale and a total of 42 on the scale | evaluated beginning and through study completion, an average of8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05659862 -
Digitally Assisted Behavioral Physical Activity Intervention in Fibromyalgia
|
N/A | |
Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
Completed |
NCT03042728 -
Impact of Inclusion of a Therapy Dog Visit as Part of the Fibromyalgia Treatment Program
|
N/A | |
Recruiting |
NCT06097091 -
Effects and Mechanisms of Pain Neuroscience Education in Patients With Fibromyalgia
|
N/A | |
Recruiting |
NCT04554784 -
Effectiveness of Bowen Therapy for Pain Management in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT03300635 -
Metabolism, Muscle Function and Psychological Factors in Fibromyalgia
|
N/A | |
Recruiting |
NCT06166563 -
Exercise, Irritable Bowel Syndrome and Fibromyalgia
|
N/A | |
Completed |
NCT03166995 -
Postural Exercises in Women With Fibromyalgia
|
N/A | |
Completed |
NCT03227952 -
Sensory Stimulation in Fibromyalgia
|
N/A | |
Recruiting |
NCT06237595 -
Vagus Nerve Stimulation in Fibromyalgia
|
N/A | |
Completed |
NCT01888640 -
Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST)
|
N/A | |
Completed |
NCT03641495 -
Pain Education and Therapeutic Exercise for Fibromyalgia
|
N/A | |
Recruiting |
NCT05581628 -
FREQUENCY OF FIBROMYALGIA IN PATIENTS WITH CELIAC DISEASE
|
||
Active, not recruiting |
NCT05128162 -
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia
|
Phase 2 | |
Completed |
NCT04674878 -
Comparison of Muscle Energy Techniques and Breathing Exercises for Functional Improvement in Fibromyalgia
|
N/A | |
Active, not recruiting |
NCT04084795 -
Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia
|
N/A | |
Completed |
NCT03129906 -
Impact of the Restriction of Sources of Gluten in Fibromyalgia Patients
|
N/A | |
Completed |
NCT05058911 -
Exposure-based Cognitive Behavior Therapy vs Traditional Cognitive Behavior Therapy for Fibromyalgia
|
N/A | |
Recruiting |
NCT04571528 -
Effectiveness of VIRTUAL FIBROWALK STUDY
|
N/A | |
Recruiting |
NCT04571853 -
New Educational Tool for FM
|
N/A |